rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Cuprina Holdings (Cayman) Limited - Class A

CUPR · Nasdaq

Health CareMedical DevicesNot moving yet

CUPR stood above a rising 150-day average in 0 of the last 45 weekly readings. It is 34.8% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−7 points in four weeks); Health Care: 26% (−10 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 45
Industry in uptrend
27% -7 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
1 (-3)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 45 weeks.

20 Apr – 19 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders1-3 on the quarter
New · exited1 · 4
Reported value$53

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Caitong International Asset Management Co., Ltdnew · filed 5 Aug 20268$53+8
30 Jun 2025 – 30 Jun 2026
134Jun 25Sep 25Dec 25Mar 26Jun 26

News

No headline names it lately.

Everyone who traded it

Nobody on record has traded it.

Same industry

RCEL Avita MedicalLeading+100%
HAE HaemoneticsLeading+48%
ATRC AtriCureLeading+47%
HTFL HeartflowLeading+47%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 2025-1.3%
Return on capital employedFY 2025 · to 31 Dec 2025-61.7%
Debt to equityFY 2025 · to 31 Dec 20250.04×
Research spendFY 2025 · to 31 Dec 2025455%
Revenue growthFY 2025 · to 31 Dec 20259.2%
Share count trendFY 2025 · to 27 Apr 2026-64.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$2.4M
Free cash flowFY 2025 · to 31 Dec 2025−$7.1M

Analyst forecasts

No analyst forecasts yet.